Kurtulmus, N. Et Al. 2022. Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?. TURKISH JOURNAL OF SURGERY , vol.38, no.1 , 60-66.

Kurtulmus, N., TOKAT, F., Duren, M., Kaya, H., Ertas, B., & İNCE, Ü., (2022). Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?. TURKISH JOURNAL OF SURGERY , vol.38, no.1, 60-66.

Kurtulmus, Neslihan Et Al. "Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?," TURKISH JOURNAL OF SURGERY , vol.38, no.1, 60-66, 2022

Kurtulmus, Neslihan Et Al. "Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?." TURKISH JOURNAL OF SURGERY , vol.38, no.1, pp.60-66, 2022

Kurtulmus, N. Et Al. (2022) . "Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?." TURKISH JOURNAL OF SURGERY , vol.38, no.1, pp.60-66.

@article{article, author={Neslihan Kurtulmus Et Al. }, title={Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?}, journal={TURKISH JOURNAL OF SURGERY}, year=2022, pages={60-66} }